You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

477 Results
Document
Mar 2018
Document
Mar 2018
Document
Mar 2018
Document
Mar 2018
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Guidelines and Advice
Status: Current
Apr 2018
Document
Jun 2018
Drug
Other Name(s): Rituxan® SC
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
riTUXimab (subcut)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025
Guidelines and Advice
Status: Current
Version: 1
Jun 2018
Document
Oct 2018
Guidelines and Advice
Status: Education and Information
Version: 1
Mar 2018

Pages